share_log

Dolby Laboratories Insiders Sold US$1.0m Of Shares Suggesting Hesitancy

Dolby Laboratories Insiders Sold US$1.0m Of Shares Suggesting Hesitancy

杜比實驗室內部人士出售了100萬美元的股票,顯示出一定的猶豫。
Simply Wall St ·  09/22 09:51

Many Dolby Laboratories, Inc. (NYSE:DLB) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

在過去的一年中,許多杜比實驗室公司(紐約證券交易所代碼:DLB)內部人士拋售了股票,這可能會引起該公司的股東的興趣。在評估內幕交易時,了解內部人士是否在買入通常比知道他們是否在賣出更有益,因爲後者可能有多種解釋。但是,當多個內部人士在特定期限內出售股票時,股東應注意,因爲這可能是一個危險信號。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

儘管我們絕不會建議投資者僅根據公司董事的所作所爲做出決定,但我們認爲完全忽視內幕交易是愚蠢的。

Dolby Laboratories Insider Transactions Over The Last Year

杜比實驗室去年的內幕交易

In the last twelve months, the biggest single sale by an insider was when the Senior VP & Chief Marketing Officer, Todd Pendleton, sold US$1.0m worth of shares at a price of US$81.69 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The good news is that this large sale was at well above current price of US$73.26. So it may not tell us anything about how insiders feel about the current share price.

在過去的十二個月中,內部人士最大的一次出售是高級副總裁兼首席營銷官託德·彭德爾頓以每股81.69美元的價格出售了價值100萬美元的股票。我們通常不喜歡看到內幕銷售,但是銷售價格越低,我們就越擔心。好消息是,此次大宗銷售遠高於當前的73.26美元。因此,它可能無法告訴我們內部人士對當前股價的看法。

All up, insiders sold more shares in Dolby Laboratories than they bought, over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

總而言之,在過去的一年中,內部人士出售的杜比實驗室的股票比購買的還要多。您可以看到下圖所示的去年的內幕交易(公司和個人)。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!

big
NYSE:DLB Insider Trading Volume September 22nd 2024
紐約證券交易所:DLB 內幕交易量 2024 年 9 月 22 日

If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.

如果你像我一樣,那麼你一定不想錯過這份免費的小盤股清單,這些股票不僅被內部人士買入,而且估值也很有吸引力。

Does Dolby Laboratories Boast High Insider Ownership?

杜比實驗室是否擁有很高的內部所有權?

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Dolby Laboratories insiders own about US$37m worth of shares. That equates to 0.5% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

對於普通股股東來說,值得檢查一下公司內部人士持有多少股票。我認爲,如果內部人士擁有該公司的大量股份,這是一個好兆頭。杜比實驗室內部人士擁有價值約3700萬美元的股票。這相當於該公司的0.5%。這種內部所有權水平不錯,但還沒有特別突出。這無疑表明了一定程度的一致性。

What Might The Insider Transactions At Dolby Laboratories Tell Us?

杜比實驗室的內幕交易可能告訴我們什麼?

It doesn't really mean much that no insider has traded Dolby Laboratories shares in the last quarter. We don't take much encouragement from the transactions by Dolby Laboratories insiders. The modest level of insider ownership is, at least, some comfort. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

上個季度沒有內部人士交易過杜比實驗室的股票,這並不意味着什麼。杜比實驗室內部人士的交易並沒有給我們帶來太多鼓勵。內部所有權的適度水平至少讓人感到欣慰。如果你像我一樣,你可能需要考慮這家公司是增長還是萎縮。幸運的是,您可以查看這份免費報告,該報告顯示了分析師對其未來的預測。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然,通過尋找其他地方,你可能會找到一筆不錯的投資。因此,來看看這份有趣的公司的免費清單吧。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論